Clinical Trials Logo

Clinical Trial Summary

The goal of this pilot interventional study is to learn about the use of an in-home harness system in children who have been treated for spinal muscular atrophy. The main questions it aims to answer are: 1. Is the in-home body weight support harness system a feasible option for families to use? 2. Is the in-home body weight support harness system a useful tool for children treated for spinal muscular atrophy? 3. Is the in-home body weight support harness system a safe tool for children treated for spinal muscular atrophy? Participants will be given an in-home body weight support harness system and taught how to use it. Families will document how often and for how long they use the system over 6 months. Children will be given tests of motor function at the beginning, 3-months, and 6-months. At the end of the study, families will be asked to fill out a questionnaire about thier experience using the system.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05715749
Study type Interventional
Source Nationwide Children's Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date September 7, 2018
Completion date December 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06300996 - Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb N/A
Completed NCT01302600 - Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients. Phase 2
Terminated NCT00439569 - Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III Phase 1/Phase 2
Active, not recruiting NCT04042025 - Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi Phase 3
Completed NCT05416034 - Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy N/A
Enrolling by invitation NCT06137612 - Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy
Recruiting NCT03709784 - Spinraza in Adult Spinal Muscular Atrophy
Active, not recruiting NCT05626855 - Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX Phase 3